Press releases

Regulatory

December 20, 2022

Nanoform appoints Antonio da Silva as Chief of Business Operations (CBO) and member of the Management Team

Regulatory

December 20, 2022

Nanoform CTO Niklas Sandler transitions to technology advisor to the CEO

Regulatory

December 7, 2022

Nanoform financial calendar for 2023

Regulatory

November 29, 2022

Nanoform Q3 and 9M 2022 report: Continued solid progress

Non Regulatory

November 15, 2022

Invitation to Nanoform’s Interim Report January-September 2022

Regulatory

October 27, 2022

Nanoform Finland Plc – Manager’s transactions – Niklas Sandler

Non Regulatory

October 17, 2022

TargTex to present Tumour Eradication in Rodents from its Nanoformed Glioblastoma drug

Regulatory

September 7, 2022

Nanoform Finland Plc – Manager’s transactions – Niklas Sandler

Regulatory

September 6, 2022

Share subscriptions based on Nanoform Finland Plc’s stock options 2-3/2019 and 1/2020

Regulatory

August 25, 2022

Nanoform Q2 and H1 2022 report: Strong momentum continues

Non Regulatory

August 10, 2022

Invitation to Nanoform’s Interim Report January-June 2022

Non Regulatory

July 14, 2022

Nanoform and Pharmanovia to breathe new life into iconic medicines

Regulatory

June 13, 2022

Nanoform Chief of Business Operations Gonçalo Andrade steps down

Regulatory

June 13, 2022

Nanoform Finland Plc – Manager’s transactions – Albert Hæggström

Regulatory

June 13, 2022

Nanoform Finland Plc – Manager’s transactions – Miguel Calado

Regulatory

June 13, 2022

Nanoform Finland Plc – Manager’s transactions – Jeanne Thoma

Regulatory

June 13, 2022

Nanoform Finland Plc – Manager’s transactions – Mads Laustsen

Regulatory

June 6, 2022

The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key employees

Regulatory

June 6, 2022

Nanoform Finland Plc – Manager’s transactions – Miguel Calado

Regulatory

June 6, 2022

Share subscriptions based on Nanoform Finland Plc’s stock options 1-2/2019 and 1/2020

Regulatory

June 2, 2022

Nanoform Finland Plc – Manager’s transactions – Niklas Sandler

Regulatory

May 30, 2022

Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade

Regulatory

May 24, 2022

Nanoform 1Q 2022 report: Quarterly record of new projects and new customers

Non Regulatory

May 10, 2022

Invitation to Nanoform’s Interim Report January-March 2022

Non Regulatory

May 4, 2022

Nanoform launches “STARMAP[®] Online” placing AI-power at the fingertips of medicine developers

Regulatory

April 12, 2022

Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade

Regulatory

April 12, 2022

Nanoform Finland Plc – Manager’s transactions – Niklas Sandler

Regulatory

April 12, 2022

Share subscriptions based on Nanoform Finland Plc’s multiple Stock Option Programs

Regulatory

April 12, 2022

Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc

Regulatory

April 12, 2022

Resolutions of Nanoform Finland Plc’s Annual General Meeting on April 12, 2022

Regulatory

March 25, 2022

Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade

Regulatory

March 23, 2022

New shares of Nanoform registered with the trade register

Regulatory

March 22, 2022

Nanoform successfully completes new share issue raising EUR 25 million to prepare for GMP manufacturing in the USA

Regulatory

March 22, 2022

Nanoform announces its intention to carry out a new share issue to raise approximately EUR 25 million to prepare for GMP manufacturing in the USA

Regulatory

March 17, 2022

Notice to the Annual General Meeting of NANOFORM FINLAND Plc

Regulatory

February 22, 2022

Nanoform 4Q and full year 2021 report: accelerating GMP growth

Non Regulatory

February 8, 2022

Invitation to Nanoform’s Q4 and full year 2021 report February 22, 2022

Non Regulatory

February 4, 2022

Nanoform signs GMP manufacturing program with TargTex following formulation success

Regulatory

January 3, 2022

Nanoform sets two new near-term business targets for 2022